-
Press Release: FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis
"FDA approval of this treatment represents a victory for the people suffering from these highly drug-resistant forms of the world's deadliest infectious disease," said Mel Spigelman, MD, president and CEO of TB Alliance. "The associated novel regimen will hopefully provide a shorter, more easily manageable and highly efficacious treatment for those in need."
- Categories
- Health Care
-
Drug Prices Can Take A Surprising Turn When A Poor Country Gets Richer
A new report, published by the Center for Global Development in June, finds that as countries move up the ladder of economic development, it becomes harder for government agencies, hospitals and health care companies to buy drugs at reasonable prices.
- Categories
- Health Care
-
In Quest for Universal Health Coverage, Kenya Faces Pharmacy Regulation Battles
A 2014 “Kenya Household Health Expenditure and Utilisation Survey” found that private clinics and pharmacies were the main private providers and that they accounted for 23% of all outpatient visits. Others have produced even higher estimates.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Ghana’s Budding Health Tech Sector is Finally Getting Deserved Global Recognition
Ghana’s long unsung health tech sector is getting global validation with two of its most promising startups being named among five winners for one of the most prestigious social enterprise awards in the world.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Award-Winning Startup Targets Affordable Medicine for Every African
MPharma is one of five social businesses to receive awards from the Skoll Foundation at this week’s Skoll World Forum, Britain’s leading event for social enterprise.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
In a Poor Kenyan Community, Cheap Antibiotics Fuel Deadly Drug-Resistant Infections
Antibiotics, the miracle drugs credited with saving tens of millions of lives, have never been more accessible to the world’s poor, thanks in large part to the mass production of generics in China and India. Across much of the developing world, it costs just a few dollars to buy drugs like amoxicillin, a first-line antibiotic that can be used against a broad range of infections, from bacterial pneumonia and chlamydia to salmonella, strep throat and Lyme disease.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
African e-health startups secure $1.5m Skoll Foundation grants
African e-health startups mPedigree and mPharma are among the five organisations to have been awarded US$1.5 million in grant funding after winning the 2019 Skoll Awards for Social Entrepreneurship.
- Categories
- Entrepreneurship, Health Care
- Region
- Sub-Saharan Africa
-
Kenya steps up Aids battle as building starts on $100m drug factory
The drugs, which will be made in Nairobi in a partnership between the government, the Global Fund and local drug manufacturers, will dramatically reduce Kenya’s spending on its Aids epidemic, said the country’s medical director, Dr Jackson Kioko.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
Parent Organization
